MAPK1 and neoplasm: In summary, we report that CNTNAP4 gene deletion mitigates aggressive sarcoma behavior in an orthotopic model of human OS, characterized by delayed tumor onset, decreased tumor progression, reduced tumor-associated angiogenesis and diminished ERK/MAPK signaling.